Posted by Michael Wonder on 28 Oct 2020
Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein based COVID-19 vaccine
28 October 2020 - COVAX Facility is led by Gavi and aims to secure successful and equitable access to COVID-19 vaccines worldwide.
Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines.
